Table 6. Toxicity of the screened compounds
| Target | CGG1) | CRA | FGP | RUT | Classification |
| Hepatotoxicity | Inactive | Inactive | Inactive | Inactive | Organ toxicity |
| Neurotoxicity | Inactive | Inactive | Inactive | Inactive | Organ toxicity |
| Cardiotoxicity | Active | Active | Active | Inactive | Toxicity endpoints |
| Immunotoxicity | Active | Inactive | Active | Active | Toxicity endpoints |
| Mutagenicity | Inactive | Inactive | Inactive | Inactive | Toxicity endpoints |
| Cytotoxicity | Inactive | Inactive | Inactive | Inactive | Toxicity endpoints |
CGG, Coumaroylgenipin gentiobioside; CRA, crocin A; FGP, feruloylgenipin gentiobioside; RUT, rutin.
Web server: (https://tox.charite.de/protox3/index.php?site=home).